MedTrace Logo

Evaluation of Spa Therapy in the Treatment of Fibromyalgia

NCT02265029 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2019-01-11

No results posted yet for this study

Summary

Fibromyalgia is a common health problem that causes widespread pain and tenderness (sensitive to touch). The pain and tenderness tend to come and go, and move about the body. There is no cure for fibromyalgia. Complementary and alternative therapy such as acupuncture, chiropractic and massage therapy, can be useful to manage fibromyalgia symptoms. Many of these treatments have not been well tested in patients with fibromyalgia. Fibromyalgia affect 3 to 4% of the general population and 14 % of patients with rheumatologic disease. Fibromyalgia is most common in women 90 % in many studies. It most often starts in middle adulthood. A chronic evolution occured for Fibromyalgic patients with a major alteration of quality of life.

Thermalgi is a randomized, multicentre, open label trial wich aims to evaluate the effects of spa therapy in rheumatologia on evolution of disability in daily life of patients with fibromyalgia.

Conditions

  • Fibromyalgia
  • Rheumatism, Muscular

Interventions

OTHER

Immediate spa treatment

spa treatment in rheumatology with sedative and antalgique techniques and mobilizing techniques (rehabilitation in pool)

OTHER

Late spa treatment

spa treatment in rheumatology with sedative and antalgique techniques and mobilizing techniques (rehabilitation in pool)

Sponsors & Collaborators

  • Floralis

    collaborator INDUSTRY

  • University Hospital, Grenoble

    collaborator OTHER

  • Association Francaise pour la Recherche Thermale

    lead OTHER

Principal Investigators

  • Caroline MAINDET DOMINICI, MD · Hospital University Grenoble

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2018-03-30
Completion
2018-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02265029 on ClinicalTrials.gov